$1.66-0.00 (-0.30%)
MindWalk Holdings Corp.
MindWalk Holdings Corp. in the Healthcare sector is trading at $1.66. Wall Street consensus targets $4.33 (3 analysts), implying a +161.8% move over the next 12 months. The stock is currently 49% below its 52-week high of $3.25, remaining 0.9% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.16Mβ | $4.12Mβ | $3.16Mβ | $6.98Mβ | $2.73M |
| Gross Profit | $2.46Mβ | $2.66Mβ | $1.53Mβ | $4.46Mβ | $1.76M |
| Operating Income | -$3.66Mβ | -$2.76Mβ | -$4.15Mβ | -$1.46Mβ | -$3.67M |
| Net Income | -$3.93Mβ | -$3.19Mβ | -$2.96Mβ | -$2.16Mβ | -$21.52M |
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through i...
MindWalk Holdings Corp (HYFT) reports a 52% revenue increase and strategic advancements, despite challenges in gross margin and rising expenses.
Moby summary of MindWalk Holdings Corp.'s Q3 2026 earnings call
Need a quote from a Motley Fool analyst? Jennifer Lynne Bath: Thank you very much, and good morning, everyone. This quarter, MindWalk Holdings Corp. reported its third consecutive year-over-year revenue increase and advanced three pipeline programs toward data readouts.
MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -50.00% and -14.34%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
Stagwell (STGW) delivered earnings and revenue surprises of +5.26% and +2.65%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?